Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

10.90
Delayed Data
As of Jun 28
 0.00 / 0.00%
Today’s Change
8.55
Today|||52-Week Range
13.73
+0.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues39.0M40.5M44.1M42.9M
 
 
 
 
 
Cost of Goods Sold5.5M5.6M5.5M5.9M
 
 
 
 
 
Depreciation And Amortization244.0K--248.0K246.0K
 
 
 
 
 
Operating ExpensesGross Income33.3M35.0M38.3M36.7M
 
 
 
 
 
General Expenses27.3M24.5M30.9M22.5M
 
 
 
 
 
Research And Development4.8M3.3M5.6M2.5M
 
 
 
 
 
Total Operating Expenses33.0M30.1M36.7M28.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.0M10.5M7.4M14.2M
 
 
 
 
 
Other Expenses-249.0K451.0K-494.0K1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income6.0M11.2M7.2M15.6M
 
 
 
 
 
Income Taxes-371.0K-1.1M-772.0K-1.0M
 
 
 
 
 
Net Income6.3M10.1M6.4M14.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.9M50.4M51.1M51.4M
 
 
 
 
 
Shares To Calculate EPS Diluted52.8M52.6M52.8M53.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.12$0.19$0.12$0.28
 
 
 
 
 
EPS Diluted$0.12$0.19$0.12$0.28